Loading clinical trials...
Loading clinical trials...
Hydroxychloroquine (HCQ) is a disease-modifying, anti-rheumatic drug that regulates immune system activity and is typically prescribed to treat rheumatoid arthritis and systemic lupus erythematosus, a...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of California, San Francisco
NCT00024479 · Rheumatic Diseases, Arthritis
NCT07469787 · Chronic Inflammatory Rheumatic Diseases of Childhood, Juvenile-Onset Chronic Inflammatory Rheumatic Diseases, and more
NCT04402086 · Rheumatic Diseases, Adult Onset Still Disease, and more
NCT04817072 · Rheumatic Diseases, Mood Disorders
NCT05786235 · Preeclampsia, Immunologic Disease, and more
University of California, San Francisco
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions